On November 16, 2026, MiniMed announced FDA clearance of MiniMed Fit, its first tubeless insulin pump.
The pump holds 300 units of insulin and is designed for up to seven days of wear without charging or changing the insulin cartridge. The full seven-day interval depends on insulin use; MiniMed says it is possible at a total daily dose below 42 units.
It includes app control and SmartGuard automated insulin-delivery technology, and is cleared for people with Type 1 or Type 2 diabetes ages 7 and older.
MiniMed plans a phased U.S. rollout starting in spring 2027, earlier than its previously expected summer 2027 timing.
The seven-day wear and “zero interruptions” language is the company’s product framing—not a guarantee for every user. Wear duration may vary with daily insulin needs.
Sources:
sec-gov-archives-edgar-data-2062583-000110465926127725-tm2629842d1-8k-htm
MiniMed gets FDA nod for tubeless insulin pump
MiniMed Wins FDA Clearance for Fit, Its First Tubeless Insulin Pump
sec-gov-archives-edgar-data-0002062583-000110465926127725-tm2629842d1-8k-htm
MiniMed Fit™ Tubeless Pump System | MiniMed
MiniMed claims quick FDA clearance for Fit patch pump
FDA Clears a Third Tubing-Free Insulin Pump, MiniMed Fit
MiniMed Delivers Strong Start to Fiscal Year 2027 with US ...
MiniMed Group receives FDA clearance for patch pump, updates 2027 EBITDA guidance By Investing.com
World's First and Only Tubeless Insulin Pump with Up to ...
MiniMed News and Press Releases | PR Newswire
MiniMed receives FDA clearance for tubeless insulin pump By Investing.com